189 related articles for article (PubMed ID: 25054464)
1. Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients.
Welch MR; Grommes C
CNS Oncol; 2013 May; 2(3):237-46. PubMed ID: 25054464
[TBL] [Abstract][Full Text] [Related]
2. Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.
Barami K; Lyon L; Conell C
World Neurosurg; 2017 Oct; 106():300-307. PubMed ID: 28698089
[TBL] [Abstract][Full Text] [Related]
3. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.
Donadon V; Balbi M; Casarin P; Vario A; Alberti A
World J Gastroenterol; 2008 Oct; 14(37):5695-700. PubMed ID: 18837086
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
5. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract][Full Text] [Related]
6. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
7. Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin.
Berstein LM; Boyarkina MP; Teslenko SY
Med Oncol; 2012 Jun; 29(2):1308-13. PubMed ID: 21298495
[TBL] [Abstract][Full Text] [Related]
8. Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.
Casadei Gardini A; Faloppi L; De Matteis S; Foschi FG; Silvestris N; Tovoli F; Palmieri V; Marisi G; Brunetti O; Vespasiani-Gentilucci U; Perrone G; Valgiusti M; Granato AM; Ercolani G; Negrini G; Tamburini E; Aprile G; Passardi A; Santini D; Cascinu S; Frassineti GL; Scartozzi M
Eur J Cancer; 2017 Nov; 86():106-114. PubMed ID: 28985579
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
10. Results of a Policy of Fast Tapering of Steroids After Resection Surgery in Glioblastoma.
Díez Valle R; Becerra Castro V; Marigil Sánchez M; Gállego Pérez-Larraya J; Núñez-Córdoba JM; Tejada Solis S
World Neurosurg; 2018 Jan; 109():e845-e852. PubMed ID: 29107723
[TBL] [Abstract][Full Text] [Related]
11. Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus.
Machado-Alba JE; Machado-Duque ME; Gaviria-Mendoza A
Diabetes Res Clin Pract; 2020 Apr; 162():108090. PubMed ID: 32088311
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study.
Spoerl S; Gerken M; Schimnitz S; Taxis J; Fischer R; Lindner SR; Ettl T; Ludwig N; Spoerl S; Reichert TE; Spanier G
Curr Oncol; 2022 Dec; 29(12):9660-9670. PubMed ID: 36547172
[TBL] [Abstract][Full Text] [Related]
13. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.
Montemurro N; Perrini P; Rapone B
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212778
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
15. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.
Hansen RA; Farley JF; Droege M; Maciejewski ML
Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679
[TBL] [Abstract][Full Text] [Related]
16. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients.
Dailey G; Kim MS; Lian JF
J Int Med Res; 2002; 30(1):71-9. PubMed ID: 11921502
[TBL] [Abstract][Full Text] [Related]
17. Metformin influences progression in diabetic glioblastoma patients.
Adeberg S; Bernhardt D; Ben Harrabi S; Bostel T; Mohr A; Koelsche C; Diehl C; Rieken S; Debus J
Strahlenther Onkol; 2015 Dec; 191(12):928-35. PubMed ID: 26329695
[TBL] [Abstract][Full Text] [Related]
18. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
[TBL] [Abstract][Full Text] [Related]
19. Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation).
Kogut SJ; Andrade SE; Willey C; Larrat EP
Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):591-8. PubMed ID: 15362081
[TBL] [Abstract][Full Text] [Related]
20. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
Bowker SL; Majumdar SR; Veugelers P; Johnson JA
Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
